Impact of Urate-Lowering Therapy on the Risk of Cardiovascular Events and All-Cause Mortality Among Individuals with Gout

被引：0
|
作者：
Choi, In Ah [1 ]
Jang, Hoyeon [2 ]
Kang, Gil-Won [2 ]
机构：
[1] Chungbuk Natl Univ Hosp, Dept Internal Med, Div Rheumatol, Cheongju, South Korea
[2] Chungbuk Natl Univ, Coll Med, Dept Hlth Informat & Management, Cheongju, South Korea
来源：
ARTHRITIS & RHEUMATOLOGY | 2018年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1128
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Effect of Urate-lowering Therapy on the Risk of Cardiovascular Disease and All-cause Mortality in Patients with Gout: A Case-matched Cohort Study
    Chen, Jiunn-Horng
    Lan, Joung-Liang
    Cheng, Chi-Fung
    Liang, Wen-Miin
    Lin, Hsiao-Yi
    Tsay, Gregory J.
    Yeh, Wen-Ting
    Pan, Wen-Harn
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (09) : 1694 - 1701
  • [2] ADHERENCE TO URATE-LOWERING THERAPY AFFECTS THE RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH GOUT
    Kim, M. J.
    Sun, J.
    Moon, K. W.
    Jang, Y.
    Shin, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 23 - 24
  • [3] Effect of Urate-Lowering Therapy on All-Cause and Cardiovascular Mortality in Hyperuricemic Patients without Gout: A Case-Matched Cohort Study
    Chen, Jiunn-Horng
    Lan, Joung-Liang
    Cheng, Chi-Fung
    Liang, Wen-Miin
    Lin, Hsiao-Yi
    Tsay, Gregory J.
    Yeh, Wen-Ting
    Pan, Wen-Harn
    PLOS ONE, 2015, 10 (12):
  • [4] Effect of urate-lowering therapy on all-cause and CVD-specific mortality in gout and hyperuricemia: a meta-analysis
    Lee, Young Ho
    Song, Gwan Gyu
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2024, 83 (SUPPL 3): : 338 - 344
  • [5] Risk of fragility fracture among patients with gout and the effect of urate-lowering therapy
    Sultan, Alyshah Abdul
    Whittle, Rebecca
    Muller, Sara
    Roddy, Edward
    Mallen, Christian D.
    Bucknall, Milica
    Helliwell, Toby
    Hider, Samantha
    Paskins, Zoe
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2018, 190 (19) : E581 - E587
  • [6] Lowering Serum Urate With Urate-Lowering Therapy to Target and Incident Fracture Among People With Gout
    Wei, Jie
    Choi, Hyon K.
    Dalbeth, Nicola
    Lane, Nancy E.
    Wu, Jing
    Lyu, Houchen
    Zeng, Chao
    Lei, Guanghua
    Zhang, Yuqing
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 (08) : 1456 - 1465
  • [7] Gout: an independent risk factor for all-cause and cardiovascular mortality
    Kuo, Chang-Fu
    See, Lai-Chu
    Luo, Shue-Fen
    Ko, Yu-Shien
    Lin, Yu-Sheng
    Hwang, Jawl-Shan
    Lin, Chi-Ming
    Chen, Hung-Wei
    Yu, Kuang-Hui
    RHEUMATOLOGY, 2010, 49 (01) : 141 - 146
  • [8] Association between urate-lowering therapy initiation and all-cause mortality in patients with type 2 diabetes and asymptomatic hyperuricemia
    Chen, Ruixuan
    Nie, Sheng
    Zhou, Shiyu
    Su, Licong
    Li, Yanqin
    Zhang, Xiaodong
    Luo, Fan
    Xu, Ruqi
    Gao, Qi
    Lin, Yuxin
    Guo, Zhixin
    Cao, Lisha
    Xu, Xin
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2024, 18 (06)
  • [9] The Effects of Pharmacological Urate-Lowering Therapy on Cardiovascular Disease in Older Adults with Gout
    Gerritsen, Martijn
    Nurmohamed, Mike T.
    DRUGS & AGING, 2024, 41 (04) : 319 - 328
  • [10] The Effects of Pharmacological Urate-Lowering Therapy on Cardiovascular Disease in Older Adults with Gout
    Martijn Gerritsen
    Mike T. Nurmohamed
    Drugs & Aging, 2024, 41 : 319 - 328
12345